| 发明名称 |
USE OF TNFALPHA INHIBITOR FOR TREATMENT OF PSORIATIC ARTHRITIS |
| 摘要 |
The invention describes methods of treating erosive polyarthritis comprising administering a TNFα antibody, or antigen-binding portion thereof. The invention also describes a method for testing the efficacy of a TNFα antibody, or antigen-binding portion thereof, for the treatment of erosive polyarthritis. |
| 申请公布号 |
US2015218269(A1) |
申请公布日期 |
2015.08.06 |
| 申请号 |
US201514681713 |
申请日期 |
2015.04.08 |
| 申请人 |
AbbVie Biotechnology Ltd. |
发明人 |
Hoffman Rebecca S.;Weinberg Mark;Banerjee Subhashis;Taylor Lori K.;Spiegler Clive E.;Tracey Daniel E.;Chartash Elliot K.;Barchuk William T.;Yan Philip;Murtaza Anwar;Salfeld Jochen G.;Fischkoff Steven A.;Granneman George R. |
| 分类号 |
C07K16/24 |
主分类号 |
C07K16/24 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
1. A method of administering adalimumab for treatment of psoriatic arthritis, comprising filling adalimumab into vessels and subcutaneously administering 40 mg of said adalimumab to a patient having psoriatic arthritis every other week. |
| 地址 |
Hamilton BM |
